Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Technology
  • Entertainment
  • Real Estate
  • Information Technology
  • Software
  • Business
Washingtoner

Study Finds Lotus Vaping Technologies' Flavored E-Liquids Reduce Smokers' Cigarettes Per Day at Significantly Higher Rate Than Tobacco Flavor
Washingtoner/10239600

Trending...
  • ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains
  • City of Tacoma Invites Community Members to Share Their Experience Crossing I-5
  • City of Tacoma Awarded Competitive State Grant to Evaluate Residential Development Regulations and Permit Processing Times
A rigorous three-month longitudinal cohort study of several of flavored bottled e-liquids demonstrated that those flavors were significantly more effective at reducing cigarettes smoked per day than tobacco-flavored e-liquids.

BOISE, Idaho - Washingtoner -- Lotus Vaping Technologies, LLC, a Boise, Idaho-based manufacturer of bottled e-liquids for use in electronic nicotine delivery systems ("ENDS") or e-cigarettes, announced today that a rigorous three-month longitudinal cohort study of several of its FreenomsTM branded flavored bottled e-liquids demonstrated that those flavors were significantly more effective at reducing cigarettes smoked per day than tobacco-flavored e-liquids.

The three-month study conducted from March 2023 to August 2023 involved 451 randomly assigned participants who were cigarette smokers, 221 of which were assigned to a control group that used only tobacco-flavored e-liquid, and 230 of which were assigned to a group that could use any of five different non-tobacco flavored bottled e-liquids, including Lotus's proprietary BluenomenomTM, StranomenonTM, X2 Cactus Jackfruit, and White Peach Raspberry flavors.

More on Washingtoner
  • Hannk And Zubie Join Forces To Shape The Next Generation Of Connected Vehicle Telematics
  • Coinfiliate Launches Platform to Helps Shoppers Earn Cashback and Creators Earn Referral Rewards
  • CinderLabs Launches AIRA Governance MCP, Putting Live AI Compliance Posture Inside Claude
  • Holiday Gambling Spending Expected to Rise 12% in December
  • RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover

At the end of three months, the average number of cigarettes smoked per day ("CPD") by the tobacco-flavored control group was reduced from 12.51 to 9.54, for a 23.72% reduction, while for the flavored e-liquid group, the average CPD was reduced from 11.70 to 6.88, for a 41.25% reduction.  The reduction in cigarettes smoked per day was thus 73.9% greater for the flavored group than the tobacco-flavored group. The study results also demonstrated statistically significant differences between several of Lotus's flavored e-liquids when compared head-to-head against tobacco-flavored e-liquids with respect to CPD reduction.

Additionally, a full 14.3% of study participants in the flavored group had quit smoking cigarettes altogether by the end of the third month—a rate that is substantially higher than that typically reported for FDA-approved nicotine replacement therapy products (9.0%).

Lotus's Director of Sales, Mike Larsen stated, "We are very excited about these study results. This study demonstrates what users of our products have known anecdotally for a long time—flavored e-liquids are more effective than tobacco flavor at promoting cigarette smoking reduction and cessation. The FDA has been asking for this data—we hope it will now take it into consideration when reviewing our premarket tobacco product applications and grant our flavored products the marketing authorizations that they deserve."

More on Washingtoner
  • Spokane Police Respond to Fatal Stabbing in Northeast Spokane
  • Claude Zdanow named Managing Director in Miami, Florida
  • Pregis Launches Sharp InfinX: On-Demand Rightsized Mailing System Delivering a Precision-Sized Mailer for Every Order
  • netElastic Announces vBNG And CGNAT 2.0 General Availability
  • Intelligence Daily Features "Producer Kirk Shaw: 90 Seconds to Make You Care"

About Lotus Vaping Technologies, LLC – Creator of NomenonsTM E-Liquids

Established in 2013, Lotus is a leading manufacturer and wholesaler of premium e-liquids in the United States providing a diverse range of vapor products for sale to adult consumers that satisfy a wide variety of consumer preferences and serve as alternatives to combustible cigarettes. Lotus is committed to responsible manufacturing processes and utilizes only the highest standards in its e-liquid production.

Media Contact
Mike Larsen
mike@lotusecigs.com


Source: Lotus Vaping Technologies, LLC
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Guardian Data Opens 42,000-Square-Foot Moonachie Facility, Doubling New Jersey Capacity
  • Spokane: Indigenous Peoples' Day Is Oct. 12
  • SecureMaine 2026 is Here -- Thursday October 8th!
  • Tacoma: Homicide Investigation – 800 Pacific Avenue
  • HW Foundation Opens Nominations for Inaugural 50 Under 50 in AI; Deadline Oct. 16
  • Pavillon 30 Years of Addiction Recovery in Western North Carolina, Earns National Accreditation
  • Safer Spokane
  • Spokane: Special Investigation Unit Seized Large Amounts of Cash and Cocaine
  • Spokane: U.S. Conference of Mayors, American Beverage Foundation Visit Youth Wellness Zone
  • Spokane: Disabled Smoke Alarm Contributes to Fatal Tiki Lodge Fire
  • Spokane Police Investigate Fatal Fire With Fire Department
  • Spokane: SPD and SFD Respond to Early Morning Fire in Downtown Apartments
  • City To Simplify Services by Routing Non-Emergency Police, Fire Calls through Spokane 311
  • ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains
  • Tacoma: Update Fourth Homicide Arrest – 2100 block of N 30th St
  • City of Tacoma Invites Community Members to Share Their Experience Crossing I-5
  • Statement from Tacoma Chief of Police Patti Jackson on Understanding the Office of Independent Investigations (OII)
  • Tacoma: 2026 AMOCAT Arts Award Winners Announced
  • City of Tacoma Awarded Competitive State Grant to Evaluate Residential Development Regulations and Permit Processing Times
  • City of Tacoma to Host 'Picture Pac Ave' Code Update Open House on October 20
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane: Police Arrest Registered Sex Offender for Child Sexual Abuse Material - 198
  • Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence - 107
  • Applicants Sought for the Tacoma Arts Commission and the Tacoma Creates Advisory Board - 103
  • Spokane: Convicted Felon Arrested in Vancouver After Eluding SPD Officers
  • City of Spokane to Install First 'Emergency Streets' Lane Closure After Weekend Fatal Crash
  • Tacoma: Applicants Sought for the Audit Advisory Board
  • ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains
  • OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
  • Inglewood Associates and Gordon Brothers Provide Update on Sale Process for 925 Euclid Avenue in Cleveland
  • CinderLabs Launches AI Agent Marketplace: Nine Pre-Built Agents for Regulated Industries

Similar on Washingtoner

  • Postmortem Pathology Highlights Private Autopsy Options for Las Vegas Families During Summer Months
  • Postmortem Pathology Offers Sacramento Families Independent Answers on a Short Timeline
  • Pavillon 30 Years of Addiction Recovery in Western North Carolina, Earns National Accreditation
  • Crossroads4Hope Launches Blood Cancer Resource Hub
  • The Human Resilience Project Embarks Upon Paraguay Expedition
  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute